# Antioxidant Role of High-Density Lipoprotein

**Authors:** Paul N. Durrington

PMC · DOI: 10.3390/antiox15020186 · Antioxidants · 2026-02-02

## Full-text entities

- **Genes:** CETP (cholesteryl ester transfer protein) [NCBI Gene 1071] {aka BPIFF, HDLCQ10}, PON1 (paraoxonase 1) [NCBI Gene 475234], LCAT (lecithin-cholesterol acyltransferase) [NCBI Gene 3931], PON2 (paraoxonase 2) [NCBI Gene 5445], LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, SAA [NCBI Gene 6287], PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, CLU (clusterin) [NCBI Gene 1191] {aka AAG4, APO-J, APOJ, CLI, CLU1, CLU2}, MPO (myeloperoxidase) [NCBI Gene 4353], APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, PON1 (paraoxonase 1) [NCBI Gene 5444] {aka ESA, MVCD5, PON}
- **Diseases:** schizophrenia (MESH:D012559), neuropsychiatric symptoms (MESH:D001523), Alzheimer's disease (MESH:D000544), acute and chronic inflammatory disorders (MESH:D020275), diabetes (MESH:D003920), Mast Cell Tumors (MESH:D007946), Parkinson's disease (MESH:D010300), Inflammatory (MESH:D007249), conditions (MESH:D020763), Neoplastic disease (MESH:D004194), injury to (MESH:D014947), Metabolic Syndrome (MESH:D024821), LCAT deficiency (MESH:D007863), hepatic steatosis (MESH:D005234), Aortic Stenosis (MESH:D001024), toxicity (MESH:D064420), mast cell tumours (MESH:D000090362), infections (MESH:D007239), cerebral infarction (MESH:D002544), atherogenic (MESH:D050197), Inflammatory arthritides (MESH:D001168), cholesteryl ester deficiency (MESH:C531854), Bicuspid Aortic Valve (MESH:D000082882), Multiple Sclerosis (MESH:D009103), HIV infection (MESH:D015658), atheromatous lesions (MESH:D058226), bipolar disorder (MESH:D001714), liver failure (MESH:D017093), depression (MESH:D003866)
- **Chemicals:** ketone (MESH:D007659), Triglycerides (MESH:D014280), carbon (MESH:D002244), lipid peroxides (MESH:D008054), oxygen (MESH:D010100), fat (MESH:D005223), Cholesterol (MESH:D002784), aldehyde (MESH:D000447), copper (MESH:D003300), phospholipids (MESH:D010743), water (MESH:D014867), cholesteryl esters (MESH:D002788), fatty acids (MESH:D005227), phosphatidyl choline (MESH:D010713), unsaturated fatty acids (MESH:D005231), organophosphate (MESH:D010755), Antioxidants 2024 (-), reactive oxygen species (MESH:D017382), lysophosphatidyl choline (MESH:D008244), hydrogen (MESH:D006859), phenyl acetate (MESH:C570634), Lipid (MESH:D008055), lactones (MESH:D007783)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Human immunodeficiency virus 1 (no rank) [taxon 11676], uncultured cyanobacterium (species) [taxon 1211], Homo sapiens (human, species) [taxon 9606], Punica granatum (granado, species) [taxon 22663]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937873/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937873/full.md

---
Source: https://tomesphere.com/paper/PMC12937873